Scheerer C, Eyerich K
Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Technische Universität München, Biedersteiner Str. 29, 80802, München, Deutschland.
Hautarzt. 2018 Mar;69(3):191-196. doi: 10.1007/s00105-018-4127-4.
Atopic dermatitis (AD) is one of the most common chronic inflammatory diseases and is also one of the most frequent reasons to consult a dermatologist. Over the past few years there has been a rapidly growing understanding of the cellular, molecular and immunological relationships as well as genetic variations, which leads to a better comprehension of the disease. Consequently, there are innovative targeted therapies in clinical studies or already approved for therapy. To make reasonable use of the new targeted therapies a good understanding of the pathogenesis is very important. In the future, stratification of patients with AD and the resulting personalized therapies will gain in importance. This review depicts the up to date state of knowledge on the complex pathogenesis of AD.
特应性皮炎(AD)是最常见的慢性炎症性疾病之一,也是患者咨询皮肤科医生最常见的原因之一。在过去几年中,人们对其细胞、分子和免疫关系以及基因变异的认识迅速增加,这使得对该疾病有了更好的理解。因此,有一些创新的靶向疗法正在临床研究中或已被批准用于治疗。为了合理使用新的靶向疗法,深入了解其发病机制非常重要。未来,对AD患者进行分层并由此进行个性化治疗将变得更加重要。本综述描述了AD复杂发病机制的最新知识状态。